In conclusion, we demonstrate the efficacy of AAV1.NT-3 gene therapy in the Sh3tc2−/−mouse model of CMT4C, the most prevalent of the recessively inherited demyelinating CMT subtype. Here, NTF3 is linked to Charcot-Marie-Tooth disease.